Early research (Phase 1)Ended earlyNCT03670069
What this trial is testing
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
Who this might be right for
Metastatic LeiomyosarcomaMetastatic Synovial SarcomaMetastatic Undifferentiated Pleomorphic Sarcoma+15 more
Fred Hutchinson Cancer Center 27